10-K/A

AMENDMENT TO ANNUAL REPORT

Company: Actinium Pharmaceuticals, Inc.
Filed: April 10, 2014
Period of Report: December 31, 2013
Accession Number: 0001213900-14-002304

View Document ↗ View on SEC.gov ↗